Low expression of microRNA-320b correlates with tumorigenesis and unfavorable prognosis in glioma

Sathornsumetee, 2006, New treatment strategies for malignant gliomas, Expert Rev Anticancer Ther, 6, 1087, 10.1586/14737140.6.7.1087

Preusser, 2015, Prospects of immune checkpoint modulators in the treatment of glioblastoma, Nat Rev Neurol, 11, 504, 10.1038/nrneurol.2015.139

Floyd, 2015, Drug encapsulated polymeric microspheres for intracranial tumor therapy: A review of the literature, Adv Drug Deliv Rev, 91, 23, 10.1016/j.addr.2015.04.008

Westphal, 2015, Circulating biomarkers for gliomas, Nat Rev Neurol, 11, 556, 10.1038/nrneurol.2015.171

Jonas, 2015, Towards a molecular understanding of microRNA-mediated gene silencing, Nat Rev Genet, 16, 421, 10.1038/nrg3965

Lu, 2015, A Single miRNA-mRNA interaction affects the immune response in a context- and cell-type-specific manner, Immunity, 43, 52, 10.1016/j.immuni.2015.04.022

Zheng, 2013, miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells, Mol Cancer Res, 11, 182, 10.1158/1541-7786.MCR-12-0534

Yuan, 2015, Variability of miRNA expression during the differentiation of human embryonic stem cells into retinal pigment epithelial cells, Gene, 569, 239, 10.1016/j.gene.2015.05.060

Yu, 2014, miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells, J Urol, 192, 1229, 10.1016/j.juro.2014.05.094

Hur, 2013, MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis, Gut, 62, 1315, 10.1136/gutjnl-2011-301846

Wang, 2015, MicroRNA-575 targets BLID to promote growth and invasion of non-small cell lung cancer cells, FEBS Lett, 589, 805, 10.1016/j.febslet.2015.02.013

Zhang, 2015, miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3, Tumour Biol, 36, 8309, 10.1007/s13277-015-3582-0

Jiang, 2016, miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia, Nat Commun, 7, 11452, 10.1038/ncomms11452

Li, 2016, Overexpression of mitochondria mediator gene TRIAP1 by miR-320b loss is associated with progression in nasopharyngeal carcinoma, PLoS Genet, 12, e1006183, 10.1371/journal.pgen.1006183

Wang, 2015, miR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cells, BMC Cancer, 15, 748, 10.1186/s12885-015-1728-5

Batistela, 2016, An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases, Int J Neurosci

Hsu, 2016, Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/β-catenin signaling, Sci Rep, 6, 30575, 10.1038/srep30575

Tana, 2017, microRNA profiling in atherosclerosis, diabetes and migraine, Ann Med, 49, 93, 10.1080/07853890.2016.1226515

Bao, 2016, NF-κB-regulated miR-99a modulates endothelial cell inflammation, Mediators Inflamm, 2016, 5308170, 10.1155/2016/5308170

Ke, 2013, miR-149 inhibits non-small-cell lung cancer cells EMT by targeting FOXM1, Biochem Res Int, 2013, 506731, 10.1155/2013/506731

Cui, 2016, miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes, Oncol Rep, 36, 487, 10.3892/or.2016.4834

Shi, 2015, MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells, Biochem Biophys Res Commun, 465, 125, 10.1016/j.bbrc.2015.07.145

Babae, 2014, Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma, Oncotarget, 5, 6687, 10.18632/oncotarget.2235

Yuan, 2015, miRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ, Biochem Biophys Res Commun, 457, 171, 10.1016/j.bbrc.2014.12.078

Varamo, 2017, MicroRNAs role as potential biomarkers and key regulators in melanoma, Genes Chromosomes Cancer, 56, 3, 10.1002/gcc.22402

Ebrahimi, 2016, Circulating microRNAs as novel potential diagnostic and prognosis biomarkers in pancreatic cancer, Curr Pharm Des, 22, 6444, 10.2174/1381612822666160817095047

Kurozumi, 2017, Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma, J Hum Genet, 62, 49, 10.1038/jhg.2016.84

Yan, 2016, Differential expression of microRNAs in plasma of patients with prediabetes and newly diagnosed type 2 diabetes, Acta Diabetol, 53, 693, 10.1007/s00592-016-0837-1

Zhang, 2016, Low serum miR-320b expression as a novel indicator of carotid atherosclerosis, J Clin Neurosci, 33, 252, 10.1016/j.jocn.2016.03.034

Qin, 2016, Potential role of circulating microRNAs as a biomarker for unexplained recurrent spontaneous abortion, Fertil Steril, 105, 1247, 10.1016/j.fertnstert.2016.01.028

Tadano, 2016, MicroRNA-320 family is downregulated in colorectal adenoma and affects tumor proliferation by targeting CDK6, World J Gastrointest Oncol, 8, 532, 10.4251/wjgo.v8.i7.532

Zhou, 2015, MicroRNA-320b promotes colorectal cancer proliferation and invasion by competing with its homologous microRNA-320a, Cancer Lett, 356B, 669, 10.1016/j.canlet.2014.10.014